Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P223 Oesophagal involvement is a predictor of anti-TNF treatment failure in patients with Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

Y. Sakata, N. Tsuruoka, M. Esaki

Saga Medical School, Internal Medicine and Gastroenterology, Saga, Japan

P224 Crohn’s disease experiences among a paediatric population: A qualitative study reviewing the agreement of symptoms discussed by children and adolescents

ECCO'20 Vienna

Year: 2020
Authors:

U. Coskun1, K. Kelly1, T. Hunter2, L. Newton3, T. Symonds3, L. Delbecque4

1Clinical Outcomes Solutions, Tuscon, USA, 2Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, USA, 3Clinical Outcomes Solutions, Folkestone, UK, 4Eli Lilly and Company, Global Patient Outcomes and Real World Evidence, Brussels, Belgium

P225 Using a standardised reporting proforma is associated with improved endoscopic assessment in UC

ECCO'20 Vienna

Year: 2020
Authors:

R. KADER1, P. Middleton2, O. Ahmad1, R. Dart3, J. McGuire1, G. Sebepos-Rogers1, J. Segal2, E. Shakweh2, M. Samaan4, Gastro London Investigative Network for Trainees (GLINT)

1Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK, 2Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK, 3Department of Gastroenterology, Royal Free NHS Foundation Trust, London, UK, 4Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

P226 Assessing the effectiveness of the nurse navigator role in an inflammatory bowel disease medical home: A retrospective cohort study

ECCO'20 Vienna

Year: 2020
Authors:

C.G. Heisler1, K. Gawdat1, N. Nazer1, M. Stewart2, B. Currie1, K. Phalen-Kelly1, J. Jones2

1Nova Scotia Health Authority, Digestive Care and Endoscopy, Halifax, Canada, 2Dalhousie University, Medicine, Halifax, Canada

P227 Defining faecal calprotectin thresholds to predict endoscopic and histological healing in ulcerative colitis (UC) by using advanced optical enhancement techniques

ECCO'20 Vienna

Year: 2020
Authors:

R. Cannatelli1,2, D. Zardo3, O. Nardone1, A. Bazarova4, U. Shivaji1,5, S.C.L. Smith1,5, S. Ghosh1,5,6, M. Iacucci1,5,6

1Institute of Translational Medicine, University of Birmingham, Birmingham, UK, 2Department of Gastroenterology, Milan, Italy, 3Department of Histopathology, Birmingham, UK, 4Institute for Biological Physics, Cologne, Germany, 5University of Birmingham, NIHR Biomedical Research Centre, Birmingham, UK, 6University of Calgary, IBD Unit, Calgary, Canada

P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?

ECCO'20 Vienna

Year: 2020
Authors:

A. Busacca1, R. Mascaretti1, L. Carrozza1, L. Guida1, S. De Grazia2, S. Peralta1, V. Calvaruso1, M. Cappello1

1Gastroenterology and Hepatology Section, PROMISE, University of Palermo, Palermo, Italy, 2Microbiology Section,- PROMISE, University of Palermo, Palermo, Italy

P229 PillCamCrohn’sCapsule: the use of a panenteric capsule endoscopy in a Portuguese centre

ECCO'20 Vienna

Year: 2020
Authors:

C. Gomes, M. Sousa, A. Ponte, R. Pinho, A. Rodrigues, J.C. Rocha Silva, E. Afecto, J. Carvalho

Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia, Vila Nova Gaia, Portugal

P230 Health-related quality of life in adolescents and young adults (AYA) with inflammatory bowel disease and its correlations with demographic, clinical, laboratory and therapeutic evaluations

ECCO'20 Vienna

Year: 2020
Authors:

J. Oba1, M. Deboni1, R. Toma1, C. Sobrado2, M. Azevedo3, A. Carlos3, M. Borba2, A. Damião3, F. Carrilho3, C. Silva4

1Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina - São Paulo University, Pediatric gastroenterology, São Paulo, Brazil, 2Hospital das Clínicas da Faculdade de Medicina - São Paulo University, Coloproctology, São Paulo, Brazil, 3Hospital das Clínicas da Faculdade de Medicina - São Paulo University, Gastroenterology, São Paulo, Brazil, 4Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina - São Paulo University, Adolescent, São Paulo, Brazil

P231 Epidemiological profile and long-term outcomes from a large PSC-IBD cohort

ECCO'20 Vienna

Year: 2020
Authors:

A.E. Caon, C. Martins, M. Cruz, L. Leite Barros, M. Azevedo, N. Queiroz, A. Carlos, L. Milane, J. Oba, M. Braga, A. Sipahi, A. Damião, E. Cançado

1Department of Gastroenterology and Hepatology, University of São Paulo School of Medicine, São Paulo, Brazil

P232 In suspected small bowel Crohn’s disease: Clinical impact of using capsule endoscopy to make decisions

ECCO'20 Vienna

Year: 2020
Authors:

R.A. Gonzalez, E.J. Gómez, L. Pereyra, J.M. Mella, G.N. Panigadi, C. Fischer, M. Roel, D. Cimmino, S. Pedreira, L.A. Boerr

Hospital Alemán, Department of Gastroenterology, Caba, Buenos Aires, Argentina

P233 Evaluating the association between faecal calprotectin and endoscopic outcomes in ulcerative colitis using the HICKORY open-label induction cohort

ECCO'20 Vienna

Year: 2020
Authors:

W. Reinisch1, B. El Azzouzi2, R. Li3, S. Lacey4, M. Daperno5, D. Mishkin6, K.T. Park7, A. Hassanali8, F. Hussain9, Y. Oh10

1Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria, 2Pharmacovigilance and Risk Management, Roche, Burgess Hill, UK, 3Product Development Biometrics, Roche, Mississauga, Canada, 4Department of Statistical Science, Roche, Welwyn Garden City, UK, 5Gastroenterology Unit, Mauriziano Hospital, Torino, Italy, 6Department of Gastroenterology, Atrius Health, Brookline, USA, 7Department of Gastroimmunology, Genentech, Inc., South San Francisco, USA, 8Department of Immunology, Genentech, Inc., South San Francisco, USA, 9Department of Medical Strategy and Science, IQVIA, Durham, USA, 10Department of Immunology, Infectious Diseases and Ophthalmology, Genentech, Inc., South San Francisco, USA

P234 Frequency detectiveness of some viral infections in patients with inflammatory bowel diseases

ECCO'20 Vienna

Year: 2020
Authors:

G. Babayeva-Sadigova1, Z. Babayev2, G. Asadova3, U. Mahmudov4, F. Quliyev5, O. Mirzazade1, IBD Group

1Department of Therapy with Course of Physiotherapy IBD Group, A.Aliyev’s State Advanced Training Institute for Doctors, Baku, Azerbaijan, 2IBD Therapy Department, Memorial Klinika, Baku, Azerbaijan, 3Department of Invasive Diagnosis and Therapy, National Center of Oncology, Baku, Azerbaijan, 4Gastroenterology and Endoscopy Department, Modern Hospital, Baku, Azerbaijan, 5Gastroenterology and Endoscopy Department, Oksigen Klinika, Baku, Azerbaijan

P235 Serological biomarkers of interstitial matrix and basement membrane remodelling correlate the Modified Mayo Endoscopic Score (mMES) for ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

J. Mortensen1, L.E. Godskesen2, M. Lindholm1, A. Krag2, M.A. Karsdal1, T. Manon-Jensen1, J. Kjeldsen2

1Nordic Bioscience A/S, Biomarkers and Research, Herlev, Denmark, 2Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark

P236 Evaluation of histological inflammation by a novel image enhanced endoscopy technique, dual red imaging, in patients with ulcerative colitis: Preliminary study

ECCO'20 Vienna

Year: 2020
Authors:

K. FUJIMOTO1, K. Watanabe2, K. Hori1, K. Kaku1, N. Kinoshita1, R. Koshiba1, K. Kojima1, T. Sato2, M. Kawai1, K. Kamikozuru1, Y. Yokoyama1, T. Miyazaki1, N. Hida1, S. Nakamura1

1Department of Inflammatory Bowel Disease- Division of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, 2Department of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Japan

P237 Annual incidence and prevalence of ulcerative colitis and Crohn’s disease from 2010 to 2017 in four Nordic countries: Results from the TRINordic study

ECCO'20 Vienna

Year: 2020
Authors:

M. Lördal1, J. Burisch2, E. Langholz3, T. Knudsen4,5, M. Voutilainen6, B. Moum7, B. Saebo8, H. Paula9, C. Malmgren10, M. Coskun11, H.O. Melberg12

1Department of Gastroenterology and Hepatology, Danderyds Hospital, Stockholm, Sweden, 2Gastrounit- Medical Division, Hvidovre University Hospital, Hvidovre, Denmark, 3Department of Medical Gastroenterology, Herlev Hospital, Herlev, Denmark, 4Department of Regional Health Research, University of Southern Denmark, O dense, Denmark, 5Department of Medicine, Hospital South West Denmark, Odense, Denmark, 6Department of Gastroenterology, University of Turku, Turku, Finland, 7Department of Gastroenterology, Oslo University Hospital, Oslo, Norway, 8Takeda AS, Medical Affairs, Asker, Norway, 9Takeda Oy, Medical Affairs, Helsinki, Finland, 10Takeda Pharma AB, Medical Affairs, Stockholm, Sweden, 11Takeda Pharma A/S, Medical Affairs, Taastrup, Denmark, 12Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway

P238 Natural history of perianal fistulizing Crohn’s disease in the Swiss IBD cohort

ECCO'20 Vienna

Year: 2020
Authors:

N. Aslan1, J.B. Rossel2, V. Pittet2, E. Safroneeva3, S. Godat1, S. Vavricka4,5, T. Greuter5, L. Biedermann5, A. Straumann5,6, M. Scharl5, M. Schaad7, D. Hahnloser8, G. Rogler5, A. Schoepfer1, Swiss IBD Cohort Study Group

1Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois CHUV and University of Lausanne, Lausanne, Switzerland, 2Institute of Social and Preventive Medicine IUMSP, Lausanne University Hospital, Lausanne, Switzerland, 3Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland, 4Vulkanplatz, Center for Gastroenterology and Hepatology, Zurich, Switzerland, 5Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, 6Pediatrician Römerhof, Swiss EoE Center, Olten, Switzerland, 7Hôpital Riviera-Chablais, Department of Internal medicine, Monthey, Switzerland, 8Centre Hospitalier Universitaire Vaudois CHUV and University of Lausanne, Division of Visceral Surgery, Lausanne, Switzerland

P239 Elderly-onset inflammatory bowel disease is associated with higher risks of infections, cancers and hospitalisation: Results from a territory-wide Hong Kong IBD registry

ECCO'20 Vienna

Year: 2020
Authors:

J.W.Y. Mak1, L.T.C. Ho2, K. Wong1, T.Y. Cheng1, T.C.F. Yip1, W.K. Leung3, M. Li4, F.H. Lo5, K.M. Ng6, S.F. Sze7, C.M. Leung8, S.W.C. Tsang9, E.H.S. Shan10, K.H. Chan11, B.C.Y. Lam12, A.J. Hui13, W.H. Chow14, S.C. Ng1, Hong Kong IBD Registry

1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong, China, 2Department of Medicine, Imperial College London, London, UK, 3Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong, China, 4Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, Hong Kong, China, 5Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, Hong Kong, China, 6Department of Medicine and Geriatrics, Prince Margaret Hospital, Hong Kong, Hong Kong, China, 7Queen Elizabeth Hospital, Department of Medicine, Hong Kong, Hong Kong, China, 8Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong, China, 9Department of Medicine, Tseung Kwan O Hospital, Hong Kong, Hong Kong, China, 10Department of Acute and Rehabilitative Medicine and Geriatrics, Caritas Medical Centre, Hong Kong, Hong Kong, China, 11Department of Medicine, North District Hospital, Hong Kong, Hong Kong, China, 12Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, Hong Kong, China, 13Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong, China, 14Department of Medicine, Yan Chai Hospital, Hong Kong, Hong Kong, China

P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study

ECCO'20 Vienna

Year: 2020
Authors:

R. Ungaro1, R. Jordan2, C. Yzet3, P. Bossuyt4, F. Baert5, T. Vanasek6, G.R. D’Haens7, V. Wilhelmus Joustra7, R. Panaccione8, G. Novacek9, W. Reinisch9, A. Armuzzi10, O. Golovchenko11, O. Prymak11, A. Goldis12, S. Travis13, X. Hébuterne14, M. Ferrante15, G. Rogler16, M. Fumery3, S. Danese17, G. Rydzewska18, B. Pariente19, E. Hertervig20, C. Stanciu21, M. Serrero22, M. Diculescu23, L. Peyrin-Biroulet24, D. Laharie25, J.P. Wright26, F. Gomollón27, G. Irina28, S. Schreiber29, S. Motoya30, P.M. Hellström31, J. Halfvarson32, J.F. Colombel33

1Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York City, USA, 2Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, USA, 3Amiens University Hospital, Gastroenterology, Amiens, France, 4Imelda GI Clinical Research Center, Gastroenterology, Bonheiden, Belgium, 5AZ Delta Roeselare, Gastroenterology, Roeselare, Belgium, 62-nd Department of Internal Medicine, University Hospital Hradec Králové, Hradec Králové, Czech Republic, 7Amsterdam UMC, Gastroenterology, Amsterdam, The Netherlands, 8University of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada, 9Medical University of Vienna, Gastroenterology, Vienna, Austria, 10Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Inflammatory Bowel Disease Unit, Rome, Italy, 11Medical Clinical Investigational Center of Medical Center Health Clinic LLC, Gastroenterology, Vinnytsia, Ukraine, 12Universitatea de Medicina si Farmacie, Gastroenterology, Timisoara, Romania, 13University of Oxford, Translational Gastroenterology Unit, Oxford, UK, 14CHU of Nice- University of Nice Sophia-Antipolis, Gastroenterology and clinical Nutrition Department, Nice, France, 15University Hospitals Leuven, Gastroenterology, Leuven, Belgium, 16University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 17Humanitas University, Istituto Clinico Humanitas, Milan, Italy, 18Central Clinical Hospital of Ministry of Interior and Aministration, Warsaw and University of JK, Gastroenterology, Kielce, Poland, 19Lille University, Claude Huriez Hospital, Lille, France, 20Skane University Hospital, Gastroenterology, Lund, Sweden, 21Grigore T. Popa University of Medicine and Pharmacy, Gastroenterology, Iasi, Romania, 22North Hospital, University of Mediterranean, Hepato-Gastroenterology Department, Marseille, France, 23University of Medicine and Pharmacy ‘Carol Davila’, Gastroenterology, Bucharest, Romania, 24Hôpital de Brabois, Hépato Gastro-Entérologie-, Nancy, France, 25Hôpital Haut-Lévêque, Service d’Hépato-gastroentérologie et Oncologie Digestive, Bordeaux, France, 26Kingsbury Hospital, Gastroenterology, Cape Town, South Africa, 27Hospital Clínico de Zaragoza- IIS Aragón, Gastroenterology, Zaragoza, Spain, 28Military Medical Academy named after S.M.Kirov, Gastroenterology, Saint-Petersburg, Russian Federation, 29Kiel University, Department of Internal Medicine I, Kiel, Germany, 30Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan, 31Uppsala University Hospital, Gastroenterology, Uppsala, Sweden, 32Faculty of Medicine and Health, Örebro University, Department of Gastroenterology, Örebro, Sweden, 33Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, USA

P241 Early prediction of outcome in acute severe ulcerative colitis (ASC): comparison of clinical and endoscopic indices at presentation, with day 3 criteria

ECCO'20 Vienna

Year: 2020
Authors:

V. Gupta1, W. Mohsen1, A. Adams1, A. Murphy1, D. Sathananthan1, S. Cripps1, O. Brain1, R. Palmer1, T. Ambrose1, B. George2, A. Walsh1, S. Travis1, J. Satsangi1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2John Radcliffe Hospital, Department of colorectal surgery, Oxford, UK

P242 Prior pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with inflammatory bowel diseases

ECCO'20 Vienna

Year: 2020
Authors:

A. Rottenstreich1, S. Fridman Lev2, R. Rotem2, T. Mishael2, B. Koslowsky2, E. Goldin2, S. Grisaru-Granovsky2, A. Bar-Gil Shitrit2

1Hadassah-Hebrew University Medical Center, Department of Obstetrics and Gynecology, Jerusalem, Israel, 2Shaare Zedek Medical Center, IBD MOM unit- Digestive Diseases Institute, Jerusalem, Israel